WhatsApp Skip to main content

Dr. Harsh J Shah

A New Option for Advanced Esophageal Cancer: Tislelizumab Shows Promise

Tislelizumab efficacy and safety compared to other anti-PD-1s a network meta-analysis of first-line therapi.DOI 10.3389fimmu.

A New Option for Advanced Esophageal Cancer: Tislelizumab Shows Promise You are here >> Home > Latest Updates >Esophagus Cancer> A New Option… Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal cancer. When it’s advanced or has spread, surgery is no longer possible, and treatment options are limited. Now, a new […]

Dr. Harsh J Shah
Dr Harsh Shah - GI & HPB Oncosurgeon in India
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.